TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
ESPR

Esperion Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

3.20$ +0.0% vs. previous close Closing price · As of: Jul 15, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ESPR
Line item 1999 2000 2001 2002 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
75.5% 91.6% 91.0% 88.0% 85.5% 97.6% 77.4% 74.5% 72.5% 87.1% 73.4% 99.4% 98.7% 97.9% 86.2% 99.5% 97.7% 98.3% 99.3%
73.8% 90.2% 89.7% 78.8% 72.1% 89.0% 72.2% 59.3% 26.2% 15.6% 12.4% 25.8% 77.5% 86.3% 54.7% 50.3% 40.0% 42.1% 36.0%
73.8% 90.2% 89.7% 87.3% 72.1% 89.0% 76.7% 59.3% 26.2% 15.6% 12.4% 25.8% 93.6% 86.3% 68.0% 67.3% 40.0% 42.1% 36.0%
– – – – – – – – – – – – – 3.5% 6.0% 13.6% 23.6% 23.3% 30.1%
– – – – – – 0.0% 0.0% 0.0% 0.0% 0.0% – – 4.6% 9.0% 14.2% 31.9% 27.5% 22.6%
– – – – 11.6% 1.6% 0.1% 0.5% 0.3% 0.3% 0.2% 0.4% 0.5% 0.4% 0.2% 0.1% – – –
– – 4.0% 6.0% – – 0.0% 0.0% 0.0% 0.0% 0.0% – – – – – – – –
– 4.5% – – 2.5% 0.7% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
64.8% 13.1% 15.1% 24.6% 377.9% 337.8% 5.4% 6.8% 2.8% 6.8% 11.9% 44.8% 90.7% 127.2% 151.6% 230.6% 321.1% 213.1% 164.8%
36.3% 9.2% 8.1% 9.6% 61.4% 234.9% 5.4% 3.8% 1.9% 6.4% 11.9% 44.8% 30.8% 26.6% 19.2% 37.2% 75.9% 71.6% 64.6%
6.2% 0.9% 1.1% 2.1% – 208.4% – 0.4% 0.5% 0.7% 0.4% – 0.2% 0.7% 3.7% 10.3% 17.7% 30.5% 19.7%
17.8% 5.1% 3.7% 3.3% 31.7% 6.5% 2.9% 1.4% 0.2% 1.9% 7.3% 31.3% 13.5% 14.7% 4.6% 9.3% 15.4% 15.0% 14.0%
– – – – 229.4% 68.4% 0.0% 3.0% 0.9% 0.4% 0.0% – 59.4% 50.8% 67.7% 104.8% 127.1% 69.1% 53.5%
35.2% 86.9% 84.9% 75.4% -277.9% -237.8% 94.6% 93.2% 97.2% 93.2% 88.1% -416.9% 9.3% -27.2% -51.6% -130.6% -221.1% -113.1% -64.8%
-160.2% -51.9% -83.4% -182.9% -1,387.0% -574.0% -86.9% -72.9% -52.2% -93.5% -142.6% -416.9% -324.2% -237.5% -289.9% -540.5% -752.8% -465.7% -348.5%
16.8% 3.8% 5.0% 8.1% 440.7% 131.4% 19.6% 11.4% 7.4% 9.2% 8.6% 18.7% 12.6% 7.8% 7.6% 26.8% 50.1% 54.4% 44.6%

Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?